FindTrial
Sign In

Find out why some people with epilepsy do not respond well to medications

Assessment of the pattern of epilepsy and identify the predictors and biomarkers of refractory epilepsy at a tertiary care hospital - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/062263
Enrollment
1000
Registered
2024-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

NIPER Guwahati
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All age and gender patients who are diagnosed with epilepsy. 2. Patients with epilepsy are examined by diagnostics protocol (seizure semiology, clinical investigation & EEG findings). 3. The AEDs must be selected based on the seizure and epilepsy types, the epilepsy syndrome, and the adverse effects associated with the drug (ILAE 2017). 4. Patients who are diagnosed with refractory epilepsy as a case, with diagnostic protocol. 5. Patients who are confirmed with drug-responsive epilepsy as control.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical characteristics of epilepsyTimepoint: December - 2025—

Secondary

MeasureTime frame
Diagnostics biomarkers of refractory epilepsyTimepoint: March - 2026;Risk factors of refractory epilepsyTimepoint: December- 2025—

Countries

India

Contacts

Public ContactKrishna Undela

National Institute of Pharmaceutical Education and Research Guwahati

krishnaundela@gmail.com9986779870

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026